Buprenorphine vs Tofacitinib

Buprenorphine vs Tofacitinib: Overview

This comparison examines the pharmacological differences between Buprenorphine and Tofacitinib.

Mechanism of Action

Buprenorphine: Partial mu-opioid receptor agonist and kappa antagonist with high receptor affinity.

Tofacitinib: Pan-JAK inhibitor with preference for JAK1 and JAK3 blocking pro-inflammatory cytokine signaling.

Pharmacokinetics

Half-life: Buprenorphine — 24-42 hours; Tofacitinib — 3.2 hours.

Chemical Properties

Molecular Formula: Buprenorphine — C29H41NO4; Tofacitinib — C16H20N6O.

Molecular Weight: Buprenorphine — 467.6430 g/mol; Tofacitinib — 312.3700 g/mol.

Type: Buprenorphine — Small molecule; Tofacitinib — Small molecule.